Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

Adv Pharm Bull. 2023;13(3): 408-410. doi: 10.34172/apb.2023.045

PMID: 37646061 PMCID: PMC10460798

Letter to Editor

Fluvoxamine Mediates Specific, Early, and Delayed SARS-CoV-2 Protection through Antioxidant and Cytoprotective Pathways via Sigma-1 Receptor Agonism

Konstantinos Papadopoulos ¹ * , Alexandra Papadopoulou ² , Tar Choon Aw ³

Cited by CrossRef: 0

1- Sharma C, Sharma S, Chaudhary R, Kumar S, Bansal S, Nair A, Gupta S. Pharmacological Insights into Fluvoxamine Maleate: σ1 Receptor Agonism, Multimodal Mechanisms, and Therapeutic Repositioning. Current Opinion in Pharmacology. 2026;:102665 [Crossref]